| APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases OA Olabisi, JY Zhang, L VerPlank, N Zahler, S DiBartolo III, JF Heneghan, ... Proceedings of the National Academy of Sciences 113 (4), 830-837, 2016 | 196 | 2016 |
| Regulation of transcription factor NFAT by ADP-ribosylation OA Olabisi, N Soto-Nieves, E Nieves, TTC Yang, XY Yang, YL Raymond, ... Molecular and cellular biology, 2008 | 120 | 2008 |
| Role of transcription factor NFAT in glucose and insulin homeostasis TTC Yang, HY Suk, XY Yang, O Olabisi, RYL Yu, J Durand, LA Jelicks, ... Molecular and cellular biology 26 (20), 7372-7387, 2006 | 95 | 2006 |
| Kidney disease-associated APOL1 variants have dose-dependent, dominant toxic gain-of-function S Datta, R Kataria, JY Zhang, S Moore, K Petitpas, A Mohamed, N Zahler, ... Journal of the American Society of Nephrology 31 (9), 2083-2096, 2020 | 45 | 2020 |
| Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies PA Broderick, OA Olabisi, DN Rahni, Y Zhou Progress in Neuro-Psychopharmacology and Biological Psychiatry 28 (3), 547-557, 2004 | 39 | 2004 |
| Evolutionarily conserved role of calcineurin in phosphodegron-dependent degradation of phosphodiesterase 4D H Zhu, HY Suk, RYL Yu, D Brancho, O Olabisi, TTC Yang, XY Yang, ... Molecular and cellular biology 30 (18), 4379-4390, 2010 | 30 | 2010 |
| JAK inhibitor blocks COVID-19 cytokine–induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids SE Nystrom, G Li, S Datta, KL Soldano, D Silas, A Weins, G Hall, ... JCI insight 7 (11), 2022 | 29 | 2022 |
| From man to fish: What can Zebrafish tell us about ApoL1 nephropathy? O Olabisi, K Al-Romaih, J Henderson, R Tomar, C MacRae, M Pollak Clinical nephrology 86 (7), 114, 2016 | 28 | 2016 |
| APOL1 nephrotoxicity: what does ion transport have to do with it? OA Olabisi, JF Heneghan Seminars in nephrology 37 (6), 546-551, 2017 | 25 | 2017 |
| Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases HY Suk, C Zhou, TTC Yang, H Zhu, YL Raymond, O Olabisi, XY Yang, ... Journal of Biological Chemistry 288 (5), 3477-3488, 2013 | 25 | 2013 |
| The role of vitamin D and oxidative stress in chronic kidney disease KC Norris, O Olabisi, ME Barnett, YX Meng, D Martins, C Obialo, JE Lee, ... International Journal of Environmental Research and Public Health 15 (12), 2701, 2018 | 20 | 2018 |
| Diagnosis, education, and care of patients with APOL1-associated nephropathy: a Delphi consensus and systematic review BI Freedman, W Burke, J Divers, L Eberhard, CA Gadegbeku, ... Journal of the American Society of Nephrology 32 (7), 1765-1778, 2021 | 18 | 2021 |
| APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease S Datta, BM Antonio, NH Zahler, JW Theile, D Krafte, H Zhang, ... The Journal of Clinical Investigation 134 (5), 2024 | 9 | 2024 |
| DiBartolo 3rd S, Heneghan JF, Schlöndorff JS, Suh JH, Yan P, Alper SL, Friedman DJ, Pollak MR: APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular … OA Olabisi, JY Zhang, L VerPlank, N Zahler Proc Natl Acad Sci USA 113 (830-837), 10.1073, 2016 | 5 | 2016 |
| Schlö ndorff, JS, Suh, JH, Yan, P., Alper, SL, et al.(2016). APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stressactivated … OA Olabisi, JY Zhang, L VerPlank, N Zahler, S DiBartolo, JF Heneghan Proc. Natl. Acad. Sci. USA 113, 830-837, 0 | 5 | |
| Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today H Trachtman, H Desmond, AL Williams, LH Mariani, S Eddy, W Ju, ... Kidney international 105 (2), 218-230, 2024 | 3 | 2024 |
| Use of race in kidney function estimation: lessons learned and the path toward health justice D Mohottige, O Olabisi, LE Boulware Annual review of medicine 74 (1), 385-400, 2023 | 3 | 2023 |
| Collapsing Glomerulopathy in Identical Twins With Lupus and High-Risk Apolipoprotein L1 (APOL1) Genotype M DeOliveira, C Feeney, C Leahy, S Nystrom, DN Howell, SS Farouk, ... Kidney International Reports 6 (9), 2501-2504, 2021 | 2 | 2021 |
| The 14th International Podocyte conference 2023: From podocyte biology to glomerular medicine S Koehler, F Hengel, B Dumoulin, L Damashek, LB Holzman, K Susztak, ... Kidney International, 2024 | 1 | 2024 |
| FSGS recurrence collaboration: report of a symposium DS Gipson, C Wang, E Salmon, R Gbadegesin, A Naik, S Sanna-Cherchi, ... Glomerular diseases 4 (1), 1-10, 2023 | 1 | 2023 |
